ENvue Medical, Inc. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$312K↓-29.7%
2025-09-30$722K↑+92.0%$510K↑+151.1%-311.2%
2025-06-30$494K↓-39.5%$-4M↓-477.2%-804.9%
2025-03-31$1M↑+11.3%$-2M↓-324.3%-180.7%
2024-12-31$444K↓-62.3%
2024-09-30$376K↓-17.9%$-998K↓-37.3%-258.0%
2024-06-30$817K↑+177.9%$-688K↑+35.9%-82.5%
2024-03-31$921K$-588K↓-136.8%-61.7%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$312K
↓-29.7% -$132K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 51 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-9.2pts
26.2%
Operating Margin↓-53.2pts
-311.2%
Net Margin↑+336.1pts
70.6%

Go deeper